p-methoxy-n-methylphenethylamine has been researched along with Orthomyxoviridae Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Fang, F; Liu, F; Shen, Y; Sun, B; Wang, S; Xie, Z; Xu, W; Zheng, M | 1 |
| Bao, L; Deng, W; Lei, R; Li, L; Liu, Z; Mei, S; Meng, S; Qin, C; Xie, L; Xu, L; Zhang, L | 1 |
2 other study(ies) available for p-methoxy-n-methylphenethylamine and Orthomyxoviridae Infections
| Article | Year |
|---|---|
Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Cross Protection; Disease Models, Animal; Female; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H9N2 Subtype; Influenza Vaccines; Injections, Intraperitoneal; Mice, Inbred BALB C; Nucleocapsid Proteins; Orthomyxoviridae Infections; p-Methoxy-N-methylphenethylamine; RNA-Binding Proteins; Survival Analysis; Vaccination; Vaccines, Synthetic; Viral Core Proteins | 2015 |
Intranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice.
Topics: Administration, Intranasal; Animals; Antibodies, Neutralizing; Antibodies, Viral; DNA, Viral; Female; Hemagglutinins; Immunization; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Mast Cells; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; p-Methoxy-N-methylphenethylamine; Pandemics; Polymerase Chain Reaction; Recombinant Proteins; Spleen | 2011 |